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Objective Implementation of the Integrated Management of Childhood Illness (IMCI)
strategy with an 11-day training course for health workers improves care for ill
children in outpatient settings in developing countries. The 11-day course
duration is recommended by the World Health Organization, which developed
IMCI. Our aim was to determine if shortening the training (to reduce cost)
reduces its effectiveness.
Methods We conducted a systematic review to compare IMCI’s effectiveness with
standard training (duration 11 days) versus shortened training (5–10 days).
Studies were identified from a search of MEDLINE, two existing systematic
reviews, and by contacting investigators. We included published or unpublished
studies that evaluated IMCI’s effectiveness in developing countries and reported
quantitative measures of health worker practices related to managing ill children
under 5 years old in public or private health facilities. Summary measures were
the median of effect sizes for all outcomes from a given study, and the
percentage of patients needing oral antimicrobials or rehydration who were
treated according to IMCI guidelines.
Findings Twenty-nine studies were included. Direct comparisons from three studies
showed little difference between standard and shortened training. Indirect
comparisons from 26 studies revealed that effect sizes for standard training
versus no IMCI were greater than shortened training versus no IMCI. Across all
comparisons, differences ranged from -3 to þ23 percentage-points, and our best
estimate was a 2 to 16 percentage-point advantage for standard training. No
result was statistically significant. After IMCI training (of any duration), 34% of
ill children needing oral antimicrobials or rehydration were not receiving these
treatments according to IMCI guidelines.
Conclusions Based on limited evidence, standard IMCI training seemed more effective than
shortened training, although the difference might be small. As sizable perform-
ance gaps often existed after IMCI training, countries should consider
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implementing other interventions to support health workers after training,
regardless of training duration.
Keywords Child health, developing country, quality improvement, systematic review,
training
KEY MESSAGES
 Based on limited evidence, standard training (typically 11 days) for health workers on Integrated Management of
Childhood Illness (IMCI) guidelines for managing ill children seemed more effective than short training (5–10 days),
although the difference might be small.
 Where possible, standard IMCI training is recommended; however, in settings where only shortened training is feasible,
core competencies should be retained (i.e. those addressing major causes of deaths for which effective interventions
exist).
 Even after IMCI training (of any duration), typically one-third of ill children needing oral antimicrobials or rehydration
were not receiving these treatments according to IMCI guidelines; thus, it is critical in all circumstances to implement
strategies in addition to training to improve health worker adherence to guidelines.
Introduction
To reduce child mortality and improve child development in
developing countries, the World Health Organization (WHO),
the United Nations Children’s Fund (UNICEF), and other
technical partners developed the Integrated Management of
Childhood Illness (IMCI) strategy (Gove et al. 1997). IMCI has
three components: improving case-management practices of
health workers (especially in outpatient health facilities),
strengthening health systems, and promoting community and
family health practices. Seventy-six countries have reportedly
scaled-up IMCI training beyond a few pilot districts (WHO
2010). Studies have demonstrated the strategy can improve
health care quality at health facilities (Armstrong Schellenberg
et al. 2004a; Amaral and Victora 2008; Arifeen et al. 2009; Rowe
et al. 2009a), although its effect on mortality is uncertain
(Armstrong Schellenberg et al. 2004b; Arifeen et al. 2009; Rowe
et al. in press).
To improve health care quality at outpatient health facilities,
IMCI includes evidence-based guidelines (Gove et al. 1997;
WHO 2005) for managing the leading causes of child deaths
(pneumonia, diarrhoea and malaria) (Black et al. 2010). WHO
recommends implementing the guidelines with an 11-day
in-service training course for health workers, a follow-up visit
to health workers’ facilities one month later to reinforce new
practices, and job-aids (e.g. a chart booklet and wall chart of
clinical algorithms, and a one-page form for recording patient
assessments, disease classifications and treatments). WHO also
recommends the following quality criteria for IMCI training: a
ratio of participants to facilitators of 4 to 1; completion of all
training modules; distribution of the IMCI chart booklet to each
trainee to keep as a reference; a minimum of 30% clinical
practice and 20 sick children managed by each trainee; and
24 participants (Lambrechts et al. 1999).
Despite favourable results from IMCI evaluations and evi-
dence from two countries that training costs in districts
implementing IMCI are similar to districts without IMCI
(Adam et al. 2005; Adam et al. 2009), concerns have been
raised that the 11-day training is too expensive and that it takes
health workers away from their clinics for too long (WHO
2003a; Goga et al. 2009). In response, many countries have
shortened courses. A recent survey of 24 countries found that
all offered shortened courses, typically lasting 5–8 days (Goga
et al. 2009). It is not known, however, whether shortening IMCI
training reduces its effectiveness. As part of WHO’s
re-examination of IMCI training strategies to identify ways to
scale-up IMCI coverage rapidly, we conducted a systematic
review to compare the effectiveness of the IMCI strategy that
used the 11-day training course (or slightly longer courses)
versus shortened training. Secondary objectives were to exam-
ine: (1) the effect of other interventions (besides IMCI training)
to strengthen health systems and health worker adherence to
IMCI guidelines; (2) the effect of IMCI over time; (3) the
overall effect of IMCI training; and (4) the absolute level of
health care quality delivered to ill children after IMCI training.
Methods
In preparing this review, Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (Moher et al. 2009)
guidelines were followed. No formal protocol was prepared,
although a short guidance document was written that described
the methods.
Definitions
IMCI training was defined as in-service training that used IMCI
materials and lasted 5 days. Courses <5 days were considered
too short to be of practical value, and the shortest courses that
countries typically offer have a duration of 5 days (Goga et al.
2009). Standard and short training were defined as IMCI
courses lasting 11 days and 5–10 days, respectively. The
adequacy of study designs and analysis-related terms are
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defined in Box 1. Study identification numbers (Study IDs) are
labels representing all reports for a given study (see Table 2).
Sources, search strategies and inclusion criteria
We searched five sources to identify relevant reports (Table 1).
We included published or unpublished studies that: (1)
compared standard versus short training (direct comparison
studies) or compared IMCI-trained health workers versus
health workers without IMCI training (indirect comparison
studies); (2) reported quantitative measures of health worker
practices related to managing ill children <5 years old in public
or private facilities; and (3) were conducted in low- or
middle-income countries (World Bank 2005). No study was
excluded because of adequacy of statistical analysis or data
collection method. Restrictions on the timing of studies and
language of reports depended on the source (Table 1). Although
the searches were conducted in 2006 and 2007, several included
reports were published after these years because our search had
identified the study reports while still in draft form, and we
followed up with investigators to obtain final versions.
As outcomes measured on extremely small samples might be
unreliable, we excluded outcome measures for a study group at
a particular time point if they were based on <15 ill child
consultations; and thus we excluded any study in which all
outcomes had a measure based on <15 consultations. Studies
of IMCI follow-up visits were excluded, as these reflected
practices when IMCI trainers were present and actively trying
to improve adherence. Post-only studies (i.e. performance only
measured after IMCI implementation) without controls were
excluded, as effect sizes cannot be estimated with this design.
Data collection methods
Data on study outcomes and attributes of IMCI courses were
collected using slightly different methods. Regarding study
outcomes, we focused on direct measures of health worker
behaviour (e.g. tasks related to treatment or counselling) and
patient knowledge on administering treatments at home.
Health outcomes (e.g. mortality) were not considered, as few
studies reported them and it was too difficult to attribute
changes in health outcomes to IMCI training. Outcome data for
Box 1 Definitions used in the review
Adequacy of study designs
 ‘First-tier’ study designs are:
– Pre-post study (i.e. performance measured before and after Integrated Management of Childhood Illness [IMCI] implementation) with
randomized controls
– Pre-post study with non-randomized controls
– Post-only study with randomized controls
– Interrupted time series with at least three data points before and after IMCI training.
 ‘Second-tier’ study designs are:
– Interrupted time series with fewer than three data points before and after IMCI training (e.g. pre-post study without controls)
– Post-only study with non-randomized controls
– Case-control study (i.e. stratify patients assessed in a cross-sectional health facility survey according to whether the consultation was
performed by an IMCI-trained or non-IMCI-trained health worker; similar to a post-only study with non-randomized controls).
Note. The classification scheme does not imply that second-tier designs are without value; indeed, many seem quite robust for
demonstrating whether IMCI had a positive effect. The classification is intended to identify studies that are relatively less
susceptible to bias.
Analysis-related terms
 An outcome measure is a numerical value for an outcome for a particular study group at a particular time point.
 A comparison is a contrast between two study groups. For example, a study with three study groups (intervention 1,
intervention 2 and controls) could have up to three comparisons (intervention 1 versus controls, intervention 2 versus
controls, and intervention 1 versus intervention 2). Multiple effect sizes could relate to a single comparison if
measurements are made over time (e.g. baseline measure, follow-up measure 1 and follow-up measure 2).
 A summary measure is an outcome derived from a group of related outcomes that are not identical. Summary measures are
used to analyse results from studies that use different outcomes. The following two summary measures were used in this
review.
– Median effect size (MES) is the median of effect sizes for all outcomes for a given comparison from a given study. For example, Study
ID 20 had seven effect sizes (-17.0, -2.7, -1.4, 7.0, 8.6, 9.8 and 10.3 percentage-points), and so the MES is the median of these seven
values (7.0 percentage-points).
– Patient treated according to IMCI guidelines (PTIG) is the percentage of patients needing an oral antimicrobial (antibiotic or
antimalarial) or oral rehydration solution who received these treatments according to IMCI guidelines. In addition to selecting
appropriate medicines, treatment almost always involved correct dosing and treatment duration
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most studies were imported from a pre-existing database on
medicine use that is supported by WHO and the International
Network for Rational Use of Drugs (INRUD) (source 3 in
Table 1) (WHO 2009) and co-ordinated by an investigator of
this review (KAH). For this database, one investigator (VI)
abstracted information from study reports and entered it into
a database (Microsoft Access, Microsoft, Inc., Redmond,
Washington), and another investigator (KAH) reviewed the
abstraction for accuracy. Before data from the WHO/INRUD
database were imported, one investigator (SYR) checked the
data against the original reports. In a few cases, discrepancies
were identified, and these were resolved through a consultative
process.
For studies in the WHO/INRUD database, after the consulta-
tive process described above, results from the WHO/INRUD
database were used, with five exceptions (Study IDs 5, 9, 11,
29, 30). In four of these exceptions (Study IDs 5, 9, 29, 30),
study groups, study areas or outcomes were defined differently
from what this review required because the purpose of our
review was different from that of the WHO/INRUD database.
For Study ID 11, the measures for one outcome were slightly
different between our review and the WHO/INRUD database
because different publications were used. For studies not in the
WHO/INRUD database, one investigator (SYR) abstracted out-
comes from study reports; and results were added to the WHO/
INRUD database. Outcome definitions varied by study; how-
ever, most studies used WHO standard IMCI indicators (WHO
2003b). Details on the outcomes are available in Box 2 and the
online annex.
Reports were also reviewed to determine: training quality;
training duration; types of health workers trained; proportion
of children managed by IMCI-trained health workers in
geographic areas where IMCI was implemented; time between
IMCI training and evaluation; sample sizes of health facilities,
health workers and patients; and additional interventions
(besides IMCI training) to strengthen IMCI implementation
(e.g. extra supervision). Whenever possible, we collected sample
size information on the data used to calculate effect sizes for
each outcome of health worker performance. If
outcome-specific sample sizes were not provided, we collected
the study’s overall sample size. If a study measured several
outcomes, we collected information on the maximum sample
size used to calculate effect sizes. For studies on short training,
we collected information on how the training was shortened. A
data manager abstracted the information from reports and
entered it into a database (Microsoft Excel, Microsoft, Inc.,
Redmond, WA, USA), and an investigator (SYR) reviewed the
abstraction for accuracy. If needed details were not in a report,
authors were contacted.
Analysis
We focused on studies with at least one effect size based on
20 consultations per study group and time point. This sample
size criterion is the same as that used in another review (Rowe
et al. 2009b).
Ideally, we needed direct comparisons of health workers who
received short training versus standard training. Only five such
studies were identified (Surjono et al. 1998; Tavrow et al. 2002;
Syla 2003; Mwinga et al. 2006; Quality Assurance Project 2006),
two of which were excluded [one lacked quantitative measures
of our outcomes (Surjono et al. 1998); and one used simulated,
not real, patients (Quality Assurance Project 2006)]. However,
as other studies compared IMCI-trained health workers with
non-IMCI-trained health workers, we also performed an indir-
ect comparison by contrasting effects of ‘standard training
versus no IMCI’ in one group of studies and ‘short training
versus no IMCI’ in a different group of studies.
Table 1 Sources and search strategies used to identify studies included in the review
Source (date of search) Search strategy
1. WHO/CAH literature search (January 2007) Searched OVID ‘‘MEDLINE R In process’’ and other non-indexed citations for reports with
key word ‘‘IMCI’’ (personal communication, A Goga, 10 May 2007)
2. WHO/CAH reports (May 2007) Searched reports from CAH and WHO regional offices (mainly unpublished reports)
(person communication, T Lambrechts, May–June 2007)
3. WHO/INRUD database (December 2006) Searched WHO/INRUD databasea for IMCI intervention studies (personal communication,
K Holloway, 27 June 2007)
4. HCPP Review Study Group (May 2006) Searched HCPP databaseb with key words ‘‘Integrated Management of Childhood Illness’’
and ‘‘IMCI’’ (personal communication, S. Rowe, May 2006)
5. Investigators of IMCI evaluations Unpublished reports from Bangladesh (personal communication, S Arifeen, 14 August
2007), Benin (personal communication, A Rowe, 10 November 2007), South Africa
(personal communication, A Goga, 13 July 2009), and Vietnam (personal communi-
cation, T Lambrechts, 1 July and 9 December 2009)
Notes:
CAH¼WHO’s Department of Child and Adolescent Health and Development; HCPP¼Health Care Provider Performance; IMCI¼ Integrated Management of
Childhood Illness; INRUD¼ International Network for Rational Use of Medicines; WHO¼World Health Organization.
aThis database is the result of a systematic review on medicine use. The project is supported by WHO and INRUD. Included studies were published from 1990–
2006 (as found in searches conducted in December 2006), written in English, French, Spanish, Portuguese or Russian, and obtained as full-text articles (i.e.
complete text of studies was required; studies were excluded if only an abstract was available). See WHO (2009) for detailed search strategy.
bThis database is the result of a systematic review on improving health care provider performance. The HCPP Review Study Group is jointly supported by staff
from the Centers for Disease Control and Prevention, Harvard University, WHO, Management Sciences for Health, the World Bank and Johns Hopkins
University. The detailed search strategy can be found in the HCPP Review protocol (HCPP Review Study Group 2008) and in Rowe et al. (2009b). Studies
published from 1951–2006 (as found in searches conducted in May 2006) were included; there were no language restrictions.
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For both direct and indirect comparisons, to balance strength
of study design, risk of bias, representativeness among de-
veloping countries and influence of outliers (Figure 1, vertical
dimension), we performed a main analysis of only studies with
first-tier designs (Box 1) and a sensitivity analysis of studies
with first- or second-tier designs. As outcomes of health worker
performance varied among studies, we needed a common
metric that could be used across as many studies as possible.
Thus, for the two analyses, we used two summary measures
(Figure 1, horizontal dimension): the median effect size (MES)
and percentage of patients needing oral antimicrobials or oral
rehydration solution who received these treatments according
to IMCI guidelines (‘patient treated according to IMCI guide-
lines’, or PTIG) (Box 1). MES reflected a study’s ‘middle’ effect
Box 2 The six most commonly used outcomes (all outcomes available in the online annex)
 Proportion of children prescribed oral rehydration solution, oral antibiotic or oral antimalarial whose caretaker knows
how to give the treatment [Integrated Management of Childhood Illness (IMCI) Priority Indicator 11 (WHO 2003b)]
 Proportion of children prescribed oral medication whose caretaker is advised on how to administer the treatment [IMCI
Supplemental Indicator 13 (WHO 2003b)]
 Proportion of children who do not need urgent referral, who need an oral antibiotic or an antimalarial who are prescribed
the drug(s) correctly, including correct dosing of drugs [IMCI Priority Indicator 7 (WHO 2003b)]
 Proportion of children with pneumonia correctly treated, including correct dosing of drugs [IMCI Supplemental Indicator
6 (WHO 2003b)]
 Proportion of children not needing antibiotic who leave facility without an antibiotic [IMCI Priority Indicator 8 (WHO
2003b)]
 Proportion of children with malaria correctly treated, including correct dosing of drugs ([IMCI Supplemental Indicator 8
(WHO 2003b)]
1. Main analysis,
outcome = MES
2. Main analysis,
outcome = PTIG
3. Sensitivity analysis,
outcome = MES
4. Sensitivity analysis,
outcome = PTIG
Include only studies with first-tier study designs
Better designs, less susceptible to bias, but fewer studies 
(potentially less representative and more influenced by outliers)
Include first- and second-tier designs
Includes weaker designs, more susceptible to bias, but more studies 
(potentially more representative and less influenced by outliers)
MES outcome
Less
comparability    ,a
but available for  
all studies  
(potentially more 
representative 
and less 
influenced by 
outliers)
PTIG outcome
Better 
comparability  ,a
but not available 
for all studies  
(potentially less 
representative 
and more 
influenced by 
outliers)
D
es
ig
n 
a
de
qu
ac
y
Outcome comparability
Figure 1 Four analytic approaches, contrasted by study design adequacy and outcome comparability Notes: MES¼Median effect size for all
outcomes of health worker performance; PTIG¼ the percentage of patients treated according to Integrated Management of Childhood Illness
guidelines (see Methods). aComparability is the degree to which outcomes from different studies have similar (or identical) definitions. Better
comparability facilitates the interpretation of comparisons across studies, with perfect comparability being identical outcomes for all studies.
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size, was available for all studies and has been used in other
reviews (Jamtvedt et al. 2006; Rowe et al. 2009b). PTIG,
although not available for all studies, had clear clinical and
public health relevance and better comparability than MES.
Altogether, we performed four sets of analyses, each with
advantages and disadvantages.
For each summary measure, we calculated effect sizes defined
as the percentage-point (%-point) ‘difference of differences’
(equation 1) (Ross-Degnan et al. 1997; WHO 2001).
Effect size ¼ ðfollow-up  baselineÞintervention
 ðfollow-up  baselineÞcontrol
ð1Þ
Effect sizes were calculated such that values >0 indicated an
improvement in case-management quality. For follow-up meas-
urements, we had to consider the possibility that health worker
performance might change (e.g. deteriorate) over time after
IMCI training. However, time between training and evaluation
(‘time since training’) varied among studies. For most analyses,
we used the one time point from each study that was furthest
from IMCI training. In additional analyses, we examined time
since training directly by using as many time points as possible
from each study. For the analyses of time since training, for one
study (Study ID 24) that used cross-sectional surveys in which
no single time since training value existed that represented all
health workers well, we accepted results from statistical models
provided by investigators that estimated IMCI training effect
sizes at several time points after training.
All analyses were performed with SAS version 9.1 (SAS
Institute Inc., Cary, NC, USA). An exact, nonparametric test
was used to test differences between medians, and linear
regression modelling with the REG procedure was used to test
for trends and in multivariable modelling. As regression models
based on extremely small samples might be unreliable, we
conducted modelling only when analyses involved 10 effect
sizes. Hypothesis testing was done with an alpha level of 0.05
and assumed each effect size had no uncertainty. Ideally,
statistical tests should account for the uncertainty of each effect
size, which depends on sample size and correlation between
outcomes of patients managed by the same health worker or at
the same health facility. However, in this review, the correl-
ations (design effects or intraclass correlation coefficients) were
not known for most studies. We considered P-values from 0.05
to 0.10 to be borderline significant.
To identify and control for confounding, we stratified effect
sizes by time since training, and whether other interventions
besides IMCI training were implemented. We also performed
statistical modelling with the above factors, plus baseline values
and a continuous variable for training duration.
Results
Literature search
Three of our sources searched databases for eligible studies:
source 1 retrieved 126 titles, source 3 retrieved 7824 titles from
the INRUD bibliography and hundreds more from a
hand-search of many thousands of documents in the WHO
archives, and source 4 retrieved 39 806 titles (Table 1). These
titles were screened by staff working on the projects described
in Table 1 (some of whom are also authors of this review).
From this screening process, 232 reports were assessed for
eligibility: 59 were included, 169 were excluded because they
did not meet inclusion criteria, and four were excluded because
IMCI training lasted <5 days. The 59 included reports
presented results from 31 distinct studies. Of these, our analysis
focused on the 29 studies with at least one effect size based on
20 consultations per study group and time point. One
additional analysis (described below), which allowed effect
sizes based on 15 consultations per study group and time
point, included all 31 studies.
General descriptive results
The 29 studies were from 23 countries (Table 2) in six WHO
regions, and 14 (48%) were published in scientific journals. Five
(17%) studies had first-tier study designs, and 24 (83%) had
second-tier designs. The median duration for standard and
short training was 11 and 7 days, respectively. Studies rarely
reported information on the IMCI training quality criteria.
However, among the 10 studies that provided any training
quality data, all reported completion of all IMCI modules; and
among nine studies that reported the time spent on clinical
practice, seven reported the minimum of 30%, one reported
daily practice, and one reported less clinical instruction than
the 11-day course (all details available in the online annex).
Nurses and physicians were the most common health worker
types studied. With short training, most courses were modified
by shortening training methods (e.g. reducing the time partici-
pants spent reading text). Among the 18 studies for which a
follow-up period could be determined (i.e. the maximum value
of time since training), the median was 22.5 months (range:
1.5, 81.0).
Nineteen (66%) of the 29 studies used the health facility
survey methodology recommended by WHO (observe consult-
ations, interview caretakers, re-examine children, then inter-
view health workers and assess the facility) (WHO 2003b). The
remaining 10 studies used similar methods, but skipped at least
one step (e.g. no re-examination). Among the studies that
reported sample size information, the majority of the studies
involved >100 patients from >10 health facilities.
The 29 studies reported on 42 distinct outcomes (Box 2), and
most had multiple outcomes. Many studies used standard IMCI
indicators (WHO 2003b). Only 15 (52%) studies used the PTIG
outcome. For the 42 outcomes, we abstracted 280 outcome
measures (Box 1); and with these measures, we calculated 117
effect sizes. The median number of outcomes per study
included in the MES calculation was three (range: 1, 8). The
29 studies had 31 comparisons (Box 1): 27 studies each had
one comparison (effect sizes based on a comparison between
two study groups, such as standard training versus no IMCI),
and two studies each had two comparisons (three study
groups).
In the 26 indirect comparison studies, the performance of
health workers without IMCI training was very poor. The
median PTIG value was 22.1% (range: 5.1, 51.4). IMCI training
(standard and short) generally had a moderate effect [median
MES increased 19.1%-points (range: -2.0, 67.5), and median
PTIG increased 26.6%-points (range: -10.0, 94.0)]. Performance
levels after training from direct and indirect comparison studies
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usually revealed considerable room for improvement. The
median of study-specific medians of all post-training outcome
measures was 75.0% (range: 40.9, 97.3), and the median of
post-training PTIG measures was 66.4% (range: 11.0, 100.0).
Thus, typically, even after IMCI training (and sometimes other
supports), 34% of ill children needing oral antimicrobials or
rehydration did not receive these treatments according to IMCI
guidelines. Table 3 summarizes the various analyses performed,
which are described in more detail below.
Direct comparison studies
A Zambian study compared standard 11-day training with a
6-day course developed for physicians (Mwinga et al. 2006). The
study, however, enrolled nurse-level workers (no physicians).
The follow-up period was 4–6 months. A Ugandan study
compared 11-day training with a 9-day course that included
computer-based training (Tavrow et al. 2002). Clinical officers
and nurses were enrolled. Follow-up was at 3–4 months. A
study from Kosovo compared 11-day training with an 8-day
course (Syla 2003). Only physicians were enrolled. Follow-up
was at 2–3 years.
MES main analysis
A direct comparison of standard versus short training (two
effect sizes from two studies; Figure 2, top graph, filled circles
in left column) suggested that standard was slightly better than
short training [median¼ 5.0%-points (range: 2.1, 7.8); no
statistical testing because of small sample]. An indirect com-
parison of standard versus short training could not be
performed because no studies with a first-tier design compared
short training to no IMCI.
PTIG main analysis
Direct comparison (two effect sizes from two studies; Figure 2,
bottom graph) showed that standard and short training were
very similar [standard was better by 2.7%-points (range: -2.7,
8.1); no statistical testing]. An indirect comparison could not be
performed because no studies with a first-tier design compared
short training to no IMCI.
MES sensitivity analysis
Direct comparison (three effect sizes from three studies;
Figure 2, top graph, all circles in left column) showed that
standard and short training were very similar [standard was
better by 2.1%-points (range: -0.5, 7.8); no statistical testing].
Indirect comparison (28 effect sizes from 26 studies) sug-
gested that standard training [median MES¼ 19.4%-points
(range: 1.8, 67.5)] was somewhat better than short training
[median MES¼ 10.7%-points (range: -2.0, 40.9)] (Figure 2, top
graph, all circles in middle and right columns). This difference
of about 9%-points was not statistically significant (P¼ 1.0).
Training duration analysed as a continuous variable revealed a
non-significant trend (P¼ 0.15) of increasing effect size with
increasing training duration. Multivariable modelling also
showed a non-significant trend (P 0.11) (details available in
the online annex). Additionally, the models suggested that
IMCI’s effect decreased as baseline performance levels
increased, although this finding was not statistically significant
(effect size decreased 0.3 to 0.4%-points per additional 1%-point
increase in baseline performance level; P-values ranged from
0.11 to 0.13).
PTIG sensitivity analysis
Direct comparison (three effect sizes from three studies; Figure 2,
bottom graph) showed that standard and short training were
very similar [short was better by 2.7%-points (range: -6.0, 8.1);
no statistical testing].
Indirect comparison (14 effect sizes from 12 studies) sug-
gested that standard training [effect size¼ 38.0%-points (range:
3.9, 94.0)] was much better than short training [effect
size¼ 15.3%-points (range: -10.0, 22.0)]. The 23%-point differ-
ence was not statistically significant (P¼ 0.19). Training dur-
ation analysed as a continuous variable revealed a borderline
significant trend of increasing effect size with increasing
training duration (5.6%-point increase per additional day of
training; P¼ 0.09); and multivariable modelling supported this
finding (P-values ranged from 0.09 to 0.11) (details available in
the online annex). Additionally, the models showed that IMCI’s
effect decreased as baseline performance levels increased,
although this finding was borderline significant at best (effect
size decreased 0.8 to 0.9%-points per additional 1%-point
increase in baseline performance level; P-values ranged from
0.09 to 0.15).
Other interventions and time since training
From the main analyses (Table 3, rows 1 and 2), standard
training with other interventions seemed much more effective
than without other interventions (35 to 42%-point difference).
In contrast, the sensitivity analyses found, for any training
duration, no significant difference between training with other
interventions versus training without other interventions (-9 to
9%-points, P-values ranged from 0.23 to 0.80). None of the
analyses revealed any evidence of deteriorating performance
over time after IMCI training. Details on both analyses are
available in the online annex.
Alternative analyses
We investigated the impact of relaxing and tightening the
sample size inclusion criteria in two alternative sensitivity
analyses. In the first analysis, effect sizes based on 15
consultations per study group and time point were included,
which allowed two studies to be added (Study IDs 32, 33). In
the second analysis, we excluded one outlier (Study ID 25)
because it had only two health facilities and unusually high
effect sizes (Table 2). Results from both analyses were similar
to those from the primary analysis (details available in the
online annex).
Training costs
Few studies reported training costs, although the direct com-
parisons did. In Zambia, standard training was US$828 per
trainee compared with US$450 per trainee for short training
(46% lower) (Mwinga et al. 2006). In Uganda, standard training
cost US$472 per trainee, and short training was US$335 per
trainee (29% lower, assuming no costs for computers) or
US$410 per trainee (13% lower, assuming computers were
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rented) (Tavrow et al. 2002). In Kosovo, costs were US$430 per
trainee for standard training and US$240 per trainee for short
training (44% lower) (Syla 2003).
From other studies, costs of standard training per trainee
were as follows: US$291 in Bolivia (personal communication, T
Lambrechts, WHO, 6 November 2007), US$793 in Kenya
(Quality Assurance Project 2006), between US$730 and
US$811 in Morocco (Naimoli 2001) and US$850 in Benin
(Rowe et al. 2009a).
Discussion
We addressed the question: does shortening IMCI in-service
training reduce its effectiveness? The review was complicated
by the fact that only two ideal studies were identified (direct
comparisons of standard versus short training with a first-tier
design). However, we did find one direct comparison with a
second-tier study design and numerous studies comparing IMCI
to no IMCI, which permitted indirect comparisons. Although
we could have been purists and included only ideal studies, we
decided to broaden our scope. In so doing, to the best of our
knowledge, this review represents the most comprehensive
examination of IMCI effectiveness on health worker perform-
ance to date. We performed layered analyses to show results
based on more and less restrictive inclusion criteria.
Additionally, as studies used a variety of outcomes, we
estimated effects for two summary measures, each with
advantages and disadvantages.
Based on the available evidence, standard in-service IMCI
training seemed more effective than short training, although
the magnitude of the difference is unclear and might be small.
Differences (standard training minus short training) from four
analyses of direct comparisons ranged from 3 to þ5%-points
(median¼ 2%-points), and differences from two analyses of
indirect comparisons ranged from 9 to 23%-points (me-
dian¼ 16%-points). Indirect comparisons that examined train-
ing duration as a continuous variable suggested that the effect
of IMCI training increases by 2 to 6%-points per additional day
of training, although at best these associations were of
borderline statistical significance. To capture the complexity of
these results, our best estimate was a range bounded by the
median values of the direct and indirect comparisons, i.e. a 2 to
16%-point advantage for standard training.
Are these modest differences relevant? In even a small
country with low access to health facility-based services, an
improvement of 2–16%-points in health worker performance
could translate annually into an additional 30 000–240 000
children treated correctly and 1000–9000 child deaths pre-
vented—a considerable impact (details available in the online
annex).
Sensitivity analyses of indirect comparisons revealed an
advantage of standard training over short training for both
summary measures, but especially for PTIG. This finding
suggests that standard training might be more effective than
short training in improving behaviours that are harder to
change. For example, prescribing all necessary drugs with
the correct dose might be harder to change than other
behaviours.
Although the effectiveness of other interventions to support
IMCI was not our focus, the review did provide some
interesting insights. First, in several analyses, IMCI’s effect
with other interventions was greater than without other
interventions; however, results varied substantially from 9 to
þ42%-points. Second, two studies with other interventions
had particularly large effect sizes; both had first-tier designs.
The largest PTIG effect was from Bangladesh (Study ID 1),
and the other interventions were purchasing essential IMCI
drugs and supplies and monthly supervision by IMCI-trained
medical officers. The second largest PTIG effect was from
Benin (Study ID 24), where investigators implemented a
package of relatively inexpensive post-IMCI-training supports
that included increased supervision, supervision of supervisors,
job aids and non-financial incentives. Over 3 years, among con-
sultations performed by IMCI-trained health workers with
study supports, the proportion of ill children receiving IMCI-
recommended treatments was 27%-points higher than for
IMCI-trained health workers in a comparison area with
‘usual’ supports.
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IMCI¼ Integrated Management of Childhood Illness; MES¼median
effect size; PTIG¼ patient treated according to IMCI guidelines. Filled
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SYSTEMATIC REVIEW OF IMCI 189
We also examined baseline and post-IMCI-implementation
values for our outcomes. At baseline (before IMCI training),
median outcome measures and PTIG measures were generally
very low. Perhaps these results should not be surprising
because health workers had not yet been trained. However, if
IMCI guidelines reflect a minimum level of care recommended
by WHO in low-resource settings, then it should be quite
concerning that, in the absence of IMCI, studies in many
countries identified grossly inadequate care for ill children.
Regarding post-IMCI performance levels, it is also concerning
that, in general, even after IMCI training (and sometimes other
supports), 34% of ill children needing oral antimicrobials or
rehydration were not receiving these treatments according to
IMCI guidelines. This result illustrates the challenge of getting
health workers to follow clinical guidelines and underscores the
importance of providing ongoing support for workers after
training.
Limitations
We tried to make the best use of all existing data, which
required a variety of analytic approaches, all of which had
important limitations (Figure 1). The heterogeneity in IMCI
implementation, study designs and outcomes precluded a
meta-analysis, which would have been preferable to our
quantitative summary. Specific limitations are as follows.
First, as previously mentioned, we identified only two direct
comparison studies with first-tier designs; and one of these
(Tavrow et al. 2002) shortened training by only 2 days. Second,
the main analysis included very few studies. Third, indirect
comparisons were susceptible to bias caused by factors that
were different between standard and short training studies,
besides training duration. For example, data on training quality
were scarce, and it is unclear to what degree the trainings were
comparable. Additionally, reliable measurement and quantita-
tive adjustment of non-training factors was challenging. We
attempted to account for two such factors (other interventions
and baseline performance levels); however, our methods were
simplistic. Fourth, the summary measure MES included differ-
ent outcomes in different studies. Thus, MES comparisons
might have been biased because some performance indicators
might be easier to improve than others.
A fifth limitation was that when comparing training
approaches, we often did not test for statistical significance
(because of small sample sizes) or we ignored the precision of
effect sizes. The ideal analytic approach, however, would have
required study datasets, which would have been too difficult to
obtain, and thus this was impractical. Sixth, when we did
perform statistical testing, we found that almost none of the
results were significant; and the few significant results close to
the 0.05 level appeared after numerous comparisons. Thus, it
seems that there was little convincing statistical evidence of a
difference between training approaches. With that said, one
must bear in mind that each data point represented an entire
study, with most studies involving >100 patients. Seventh, only
about two-thirds of studies used re-examinations to make a
‘gold standard’ determination of the child’s IMCI illness
classifications. Without such a standard, training effects
might be overestimated, depending on health workers’ ability
to classify illnesses correctly. Finally, in the analysis of IMCI’s
effect over time, there was insufficient evidence to conclude
that the effect increased or decreased over time since training
for either standard or short training. However, ‘time since
training’ values were missing for some studies, and many
studies reported results for just one time point.
Conclusions
Four broad conclusions can be drawn from this analysis. First,
there were too few direct comparisons of standard and short
training with first-tier study designs to conclude firmly whether
shortening IMCI training reduces its effectiveness (and if so, to
what degree effectiveness is reduced). Additional direct com-
parisons with first-tier designs would be needed to answer the
question definitively. While such studies would be welcome,
they might be difficult to realize because countries usually do
not implement two different types of IMCI training at the same
time. Moreover, programme implementers and donors often
resist the use of first-tier study designs.
Second, standard in-service IMCI training seemed more
effective than short training, although the magnitude of the
difference is unclear, ranging from -3 to þ23%-points. Our best
estimate was a difference of 2–16%-points. Third, all three
direct comparison studies found that shortening IMCI training
reduces costs. Direct training costs for short training were 13–
46% lower than standard training, health workers were away
from their clinics for a shorter time, and presumably IMCI
course facilitators spent less time on training.
Fourth, post-IMCI-implementation outcome values show that
even after IMCI training, considerable room for improvement
exists. Although this review focused on training duration, an
equal (or greater) consideration should be given to designing
and implementing other interventions to support health work-
ers after IMCI training, regardless of training duration. Results
from this and other reviews (Ross-Degnan et al. 1997; WHO
2001; Rowe et al. 2005; Rowe et al. 2009b; WHO 2009) clearly
show that not all such interventions have the same effect, and
therefore we recommend strongly that additional research be
conducted to identify effective and affordable interventions to
improve and maintain health worker performance in
low-resource settings. Similarly, research is needed on the
effectiveness of pre-service training on IMCI guidelines, as such
an approach might render moot concerns about the difference
between shorter versus longer in-service training duration.
Policy implications
Based on limited evidence, standard training seemed more
effective than short training, although the difference might be
small. Where possible, standard training is recommended.
However, we acknowledge that in some settings only shortened
training is feasible. When countries need to shorten training,
WHO recommends that core competencies should be retained
(i.e. those addressing major causes of deaths for which effective
interventions exist) (WHO 2007). In all circumstances, it is
critical to implement strategies to strengthen health systems in
addition to training in IMCI.
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